Ear-based vagus nerve stimulation to boost decision-making and other thinking skills in people with Parkinson's and healthy adults
Official title: Investigation of Vagus Nerve Stimulation to Augment Executive Functioning
Run by University of Colorado, Denver · NCT07424365 · Data updated 2026-11-12
This project will try gentle electrical stimulation of the ear (taVNS) to see if it improves decision-making and other thinking skills in people with Parkinson's disease and in healthy adults.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | University of Colorado, Denver Academic / other |
| Locations | 1 site (Aurora, Colorado) |
| Status | Recruiting |
| Started | May 19, 2025 |
| Main results expected | May 2028 |
| Study ends | May 2028 |
| Registry record updated | February 20, 2026 |
| Trial ID | NCT07424365 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–65 who can give informed consent and follow instructions, including healthy volunteers and people with Parkinson's disease who do not have severe motor or cognitive impairments.
✕Probably not a fit
People with implanted electronic medical devices (e.g., pacemakers, cochlear implants, neurostimulators), abnormal or infected ears, uncontrolled medical conditions, uncorrected visual impairments, or severe motor/cognitive impairment may not be eligible or likely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-site pilot pairs noninvasive transcutaneous auricular vagus nerve stimulation (taVNS) with cognitive training to test safety, feasibility, and potential cognitive benefits in healthy adults and people with Parkinson's disease. The study includes a longitudinal component in which participants are prospectively assigned to active or sham stimulation based on enrollment order, and an acute component in healthy participants who receive both sham and active stimulation in randomized order. Outcome measures focus on executive function tasks such as decision-making and problem-solving, along with safety and tolerability monitoring. The goal is to gather preliminary data to inform larger controlled trials.
Why it matters
Potential benefit: If successful, taVNS paired with cognitive training could improve executive functions like decision-making and problem-solving and offer a noninvasive therapy option for people with PD and others with cognitive concerns.
How similar studies have gone: Small prior studies have shown that taVNS can alter attention and memory measures in some participants, but evidence for lasting cognitive improvement—especially in Parkinson's disease—is preliminary and mixed.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Individuals aged 18-65. 2. Ability to sign informed consent. 3. Ability to follow written and verbal instructions. 4. For the PD group, a clinical diagnosis of Parkinson's disease without severe motor or cognitive impairments. Exclusion Criteria: 1. Current uncontrolled and/or clinically significant medical condition. 2. Abnormal ear anatomy or active ear infection. 3. Electronic medical implants, such as pacemakers, cochlear prosthesis, neuro-stimulators. 4. Uncorrected visual impairments that would interfere with task performance. (6) Other significant diseases or disorders that might impair study participation.
Where it's running
-
Clinical Translational Research Center at CU Anschutz
Aurora, Colorado, United States Recruiting
Study contacts
- Principal investigator: Cristin Welle, PhD — Dept. of Neurosurgery, School of Medicine, University of Colorado Anschutz Medical Campus
- Study coordinator: Elise R Carter
- Email: elise.carter@cuanschutz.edu
- Phone: 3094335932
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comprehensive assessment of neurodegeneration and dementia
This project will collect brain scans, cognitive tests, and biological samples over time to see how dementia and related conditions progress in adults aged 50–90, including people with Parkinson's and people without cognitive problems.
-
Rural Veterans and Care Partners Walking Program
A virtual walking program is tested to see if it can help Veterans with mild cognitive impairment and their care partners in rural areas walk more each day.
-
China HEAD: a large community study on healthy aging and dementia
This study tests whether collecting health, imaging, and biospecimen data from adults in China can help predict who will develop Alzheimer’s disease and related dementias.
-
Oura Ring validation for sleep using gold-standard sleep tests
This study tests how well the Oura Ring matches the gold-standard sleep test ( PSG ) in healthy adults and people with sleep apnea.
-
Magnetic field maps with NV sensors for non-invasive heart measurements
This study tests whether diamond-based NV magnetometers can non-invasively detect and map the heart's magnetic field in healthy adults.
-
Automated language analysis to help diagnose neurodegenerative diseases
A multilingual AI-powered language test is being tried to see if speech and language patterns can help differentiate Alzheimer’s, frontotemporal dementia, Lewy body dementia, and Parkinson’s from healthy aging.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.